Literature DB >> 10335547

MAOA: association and linkage studies with lithium responsive bipolar disorder.

G Turecki1, P Grof, P Cavazzoni, A Duffy, E Grof, B Ahrens, A Berghöfer, B Müller-Oerlinghausen, M Dvoráková, E Libigerová, M Vojtechovsky, P Zvolsky, R Joober, A Nilsson, H Prochazka, R W Licht, N A Rasmussen, M Schou, P Vestergaard, A Holzinger, C Schumann, K Thau, G A Rouleau, M Alda.   

Abstract

A number of association studies have investigated the role of the monoamine oxidase A (MAOA) gene in the susceptibility to bipolar disorder. Although some studies have reported positive findings, there remains some controversy, because results from different studies have not been consistent. A common explanation for inconsistencies between studies is genetic heterogeneity. We have focused on lithium responsive bipolar disorder as a way to reduce heterogeneity. In this study, we investigated the role of MAOA in lithium responsive bipolar patients using association and linkage study designs. The investigation used 138 patients and 108 normal controls. In addition, 25 families were also studied. Our results were not supportive of a major role of MAOA in the predisposition to bipolar disorder.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10335547

Source DB:  PubMed          Journal:  Psychiatr Genet        ISSN: 0955-8829            Impact factor:   2.458


  12 in total

Review 1.  Review of bipolar molecular linkage and association studies.

Authors:  Wade Berrettini
Journal:  Curr Psychiatry Rep       Date:  2002-04       Impact factor: 5.285

2.  Genetics of major mood disorders.

Authors:  Wade Berrettini
Journal:  Psychiatry (Edgmont)       Date:  2004-09

Review 3.  The Role of Pharmacogenomics in Bipolar Disorder: Moving Towards Precision Medicine.

Authors:  Claudia Pisanu; Urs Heilbronner; Alessio Squassina
Journal:  Mol Diagn Ther       Date:  2018-08       Impact factor: 4.074

Review 4.  The promise and reality of pharmacogenetics in psychiatry.

Authors:  Peter P Zandi; Jennifer T Judy
Journal:  Psychiatr Clin North Am       Date:  2010-03

Review 5.  Genetics of bipolar affective disorder.

Authors:  J I Nurnberger; T Foroud
Journal:  Curr Psychiatry Rep       Date:  2000-04       Impact factor: 5.285

6.  Pharmacogenomics of mood stabilizers in the treatment of bipolar disorder.

Authors:  Alessio Squassina; Mirko Manchia; Maria Del Zompo
Journal:  Hum Genomics Proteomics       Date:  2010-08-03

Review 7.  Long-term responsiveness to lithium as a pharmacogenetic outcome variable: treatment and etiologic implications.

Authors:  Firoza Mamdani; Iris Jaitovich Groisman; Martin Alda; Gustavo Turecki
Journal:  Curr Psychiatry Rep       Date:  2003-12       Impact factor: 5.285

Review 8.  Molecular actions and clinical pharmacogenetics of lithium therapy.

Authors:  Adem Can; Thomas G Schulze; Todd D Gould
Journal:  Pharmacol Biochem Behav       Date:  2014-02-15       Impact factor: 3.533

Review 9.  Genetic influences on response to mood stabilizers in bipolar disorder: current status of knowledge.

Authors:  Janusz K Rybakowski
Journal:  CNS Drugs       Date:  2013-03       Impact factor: 5.749

10.  Association analysis of monoamine oxidase A gene and bipolar affective disorder in Han Chinese.

Authors:  Yi-Mei J Lin; Fabian Davamani; Wei-Chih Yang; Te-Jen Lai; H Sunny Sun
Journal:  Behav Brain Funct       Date:  2008-05-24       Impact factor: 3.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.